Available Technologies

11 - 11 of 11 Results

Development of Covalent Inhibitors of the Papain-like Protease from SARS-CoV-2

There is a critical need for new antiviral drugs for treating infections of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).